NCI’s Cancer Trends Progress Report announced 2023 Incidence and Mortality Data
On Sep. 3, 2024, the National Cancer Institute (NCI) announced that the latest Cancer Trends Progress Report included…
Artificial Intelligence | Biotechnology | CRISPR | Genomics | Life Science History | Life Science News | Medicine | NIH | Non-Profit Research | Therapeutics | Vaccine
Biden announced $150 million in research grants as part of his ‘moonshot’ push to fight cancer
On Aug. 13, 2024, President Joe Biden announced $150 million in awards from the Advanced Research Projects Agency…
NIH launched research network to evaluate emerging cancer screening technologies
On Feb. 21, 2024, the National Institutes of Health (NIH) announced it had launched a clinical trials network…
W. Kimryn Rathmell, M.D., Ph.D., began work as 17th director of the National Cancer Institute
On Dec. 18, 2023, W. Kimryn Rathmell, M.D., Ph.D., began work as the 17th director of the National…
U.S. Department of Health and Human Services released National Cancer Plan
On Apr. 3, 2023, the U.S. Department of Health and Human Services (HHS) released a National Cancer Plan,…
Monica Bertagnolli began work as 16th director of the National Cancer Institute
On Oct. 3, 2022, Monica M. Bertagnolli, M.D., started as the 16th director of the National Cancer Institute….
NIH launched program to offer molecular characterization of childhood cancers
On Mar. 21, 2022, in support of the Cancer Moonshot? goal of fostering data sharing in cancer research,…
Researchers generated the first complete, gapless sequence of a human genome
On Mar. 21, 2022, in support of the Cancer Moonshot goal of fostering data sharing in cancer research,…
Artificial Intelligence | Biotechnology | CRISPR | Genomics | Life Science History | Life Science News | Medicine | NIH | Non-Profit Research | Therapeutics | Vaccine
Cancer MoonShot program reignited
On Feb. 2, 2022, President Biden announced a reignition of the Cancer Moonshot, that highlighted new goals: to…
Asthma drug budesonide shortened recovery time in non-hospitalised patients with COVID-19
On Apr. 12, 2021, Oxford University reported that early treatment with inhaled budesonide shortened recovery time by a…
Antiviral drug Favipiravir investigated as a possible COVID-19 treatment for at-home recovery in PRINCIPLE trial
On Apr. 8, 2021, Oxford University announced that favipiravir was to be investigated in the UK as part…
PRINCIPLE found antibiotics azithromycin and doxycycline not generally effective treatments for COVID-19
On Jan. 25, 2021, scientists at the University of Oxford reported that after reviewing interim analyses of both…
Patients in cancer remission at high risk for severe COVID-19 illness
On Jan. 21, 2021, Penn Medicine reported that patients with inactive cancer and not currently undergoing treatments also…
NIH launched the Serological Sciences Network for COVID-19, announced grant and contract awardees
On Oct. 8, 2020, the National Cancer Institute (NCI) launched the Serological Sciences Network for COVID-19 (SeroNet), an…
Biotechnology | COVID-19 | Disease | Life Science News | Medicine | NIH | Therapeutics
La Jolla Institute for Immunology awarded $1.4 million to study COVID-19 in Latino Americans
On Oct. 8, 2020, the La Jolla Institute for Immunology (LJI) announced it had been granted $1.4 million…
NCI and Cancer Research UK launched Cancer Grand Challenges partnership to support bold new ideas for cancer research
On Aug. 27, 2020, the National Cancer Institute (NCI) announced a partnership with Cancer Research UK to fund…
Roswell Park’s Dr. Pawel Kalinski lead $145 million NCI-funded immunotherapy effort
On Mar. 31, 2020, a team led by Pawel Kalinski, MD, PhD, of Roswell Park Comprehensive Cancer Center…
UArizona Cancer Center received $69M grant forsSkin cancer prevention study
On Mar. 19, 2020, The UArizona Cancer Center announced it was awarded a five-year, $6.9 million prestigious Program…
Testing with combined biopsy method improves prostate cancer diagnosis in NCI study
On Mar. 4, 2020, a method of testing for prostate cancer developed at the National Cancer Institute (NCI)…
Winship Cancer Institute was awarded a $500,000 grant from the National Cancer Institute (NCI) for new cellular therapies
On Sep. 6, 2019, the Winship Cancer Institute was awarded a $500,000 grant from the National Cancer Institute…
Masonic Cancer Center researchers awarded $8.5 million dollar grant to research metastatic breast cancer
On Aug. 15, 2019, Masonic Cancer Center researchers Reuben Harris, PhD and Douglas Yee, MD announced that they…
Siteman Cancer Center awarded $78 million to expand clinical trials access
On Aug. 1, 2019 the Siteman Cancer Center announced it was awarded a six-year, $7.8 million grant from…
Sylvester Comprehensive Cancer Center announced it had received NCI designation
On Jul. 29, 2019, Sylvester Comprehensive Cancer Center announced it had achieved National Cancer Institute (NCI) designation, becoming…
Perlmutter Cancer Center earned Comprehensive status from the National Cancer Institute
On Feb. 6, 2019, Laura and Isaac Perlmutter Cancer Center at NYU Langone Health was designated a Comprehensive…
The Stephenson Cancer Center received NCI designation
On May 2, 2018, the Stephenson Cancer Center received National Cancer Institute (NCI) designation. The Stephenson Cancer Center,…
The Lombardi Comprehensive Cancer Center became the 16th National Cancer Institute-designated Comprehensive Cancer Center
In 2018, the Lombardi Comprehensive Cancer Center became the 16th National Cancer Institute-designated Comprehensive Cancer Center funded with…
Norman “Ned” Sharpless was sworn in as the 15th Director of the National Cancer Institute
On Oct. 17, 2017, Norman “Ned” Sharpless was sworn in as the 15th Director of the National Cancer…
Emory University selected by National Cancer Institute (NCI) for participation in elite national network for cancer therapeutic discovery
On Oct. 2, 2017, Emory University was selected by the National Cancer Institute (NCI) for participation in an…
Biotechnology | Diagnostics | Genomics | Life Science News | Medical Device | Non-Profit Research | Therapeutics
OHSU Knight Cancer Institute earned National Cancer Institute’s highest distinction
On Jul. 10, 2017, the OHSU Knight Cancer Institute was awarded the National Cancer Institute’s premier status: Comprehensive…
Biotechnology | Diagnostics | Life Science News | Medicine | Non-Profit Research | Pharmaceutical | Therapeutics
National Cancer Institute awarded Fred Hutch $24 million to operate Contact Center for patients
On May 24, 2017, the National Cancer Institute (NCI) awarded $24 million to Fred Hutchinson Cancer Research Center…